Rituxan (rituximab) - Roche
Ocrevus (ocrelizumab) - Roche
Neupogen (filgrastim) - Kyowa Kirin, Amgen
Kesimpta (ofatumumab subcutaneous) - Novartis, Genmab
Briumvi (ublituximab-xiiy) - TG Therap
Uplizna (inebilizumab-cdon) - Mitsubishi Tanabe, Amgen
http://www.ncbi.nlm.nih.gov/pubmed/40537081
 
; Chu-Yueh Guo; Greer Waldrop; Jeffrey M Gelfand; Michael R Wilson; Nikki Sisodia; Riley Bove; Samuel Pleasure; Scott S Zamvil; Shane Poole
 
Jun 20, 2025
 
Next